Table 1.
Baseline characteristics
| Baseline characteristics | n = 37 (%) |
|---|---|
| Age in years, median (range) | 27 (15–58) |
| Male, n (%) | 20 (54) |
| Duration of symptoms, in months Median(range) | 2 (1–12) |
| B symptoms, n (%) | 13 (35) |
| PS (ECOG scale) n (%) | |
|
0 1 2 3–4 |
2 (5.4) 28 (75.7) 4 (10.8) 3 (8.1) |
| Bulky disease, n (%) | |
|
> 7 cm > 10 cm |
36 (97.3) 23 (62.2) |
| Ann Arbor Stage, n (%) | |
|
I II III IV |
5 (13.5) 12 (32.4) 5 (13.5) 15 (40.5) |
| Extranodal sites, n (%). | |
|
0 1 ≥ 2 |
17 (45.9) 8 (21.6) 12(32.4) |
|
Pleural effusion, n (%) Pericardial effusion, n (%) |
8 (21.6) 4 (10.8) |
| IPI score | |
|
1 2 3 4 |
7 (18.9) 14 (37.8) 13 (35.1) 3 (8.1) |
| Serum albumin at baseline | |
|
Median (range) in g/dL < 4 g/dL, n (%) |
4.1 (2.0–4.5) 15 (40.5) |
| Hemoglobin at baseline | |
|
Median (range) in g/dL < 11 g/dL, n (%) |
12.3 (8.2–16.3) 9 (24.3) |
| LDH at baseline* | |
| Median (range) in U/L | |
| > 2 times of upper limit of normal, n (%) |
413 (210–1851) 15 (40.5) |
*LDH Reference Range: 100–190 U/L